Showing results (31-40 of 395) with videos related to
Sort By:
Pageof 40
AIDS Research and Human Retroviruses|September 11, 1992
Analysis of HIV-1 envelope mutants and pseudotyping of replication-defective HIV-1 vectors by genetic complementationE L Delwart, G L Buchschacher, E O Freed, et al.Proceedings of the National Academy of Sciences of the United States of America|January 11, 1992
A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivityE O Freed, E L Delwart, G L Buchschacher, et al.AIDS Research and Human Retroviruses|September 1, 1992
Studies on the role of the V3 loop in human immunodeficiency virus type 1 envelope glycoprotein functionS H Chiou, E O Freed, A T Panganiban, et al.Journal of Virology|June 23, 2000
Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2',3'-dideoxy-3'-thiacytidineE K Halvas, E S Svarovskaia, E O Freed, et al.Journal of Virology|August 1, 1994
Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle productionE O Freed, J M Orenstein, A J Buckler-White, et al.Journal of Virology|May 1, 1995
Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1G Englund, T S Theodore, E O Freed, et al.Molecular and Cellular Biology|October 1, 1987
Transformation of NIH 3T3 cells by cotransfection with c-src and nuclear oncogenesD Shalloway, P J Johnson, E O Freed, et al.Journal of Virology|September 1, 1996
Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage culturesR L Willey, R Shibata, E O Freed, et al.Drugs Under Experimental and Clinical Research|January 1, 1989
Synthesis and antitumour activity of 4-nitroso-4-(2-chloroethyl)semicarbazidesR G Gugova, Z D Raikov, S G Zakhariev, et al.Journal of Virology|September 5, 2001
Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cellsS Tang, T Murakami, B E Agresta, et al.Pageof 40